IBDEI12N ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17222,1,3,0)
 ;;=3^Sarcoidosis of Lung w/ Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,17222,1,4,0)
 ;;=4^D86.2
 ;;^UTILITY(U,$J,358.3,17222,2)
 ;;=^5002444
 ;;^UTILITY(U,$J,358.3,17223,0)
 ;;=D86.89^^88^889^48
 ;;^UTILITY(U,$J,358.3,17223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17223,1,3,0)
 ;;=3^Sarcoidosis of Other Sites
 ;;^UTILITY(U,$J,358.3,17223,1,4,0)
 ;;=4^D86.89
 ;;^UTILITY(U,$J,358.3,17223,2)
 ;;=^5002453
 ;;^UTILITY(U,$J,358.3,17224,0)
 ;;=D86.9^^88^889^51
 ;;^UTILITY(U,$J,358.3,17224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17224,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,17224,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,17224,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,17225,0)
 ;;=D86.86^^88^889^39
 ;;^UTILITY(U,$J,358.3,17225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17225,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,17225,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,17225,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,17226,0)
 ;;=D86.87^^88^889^43
 ;;^UTILITY(U,$J,358.3,17226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17226,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,17226,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,17226,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,17227,0)
 ;;=D86.3^^88^889^49
 ;;^UTILITY(U,$J,358.3,17227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17227,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,17227,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,17227,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,17228,0)
 ;;=D86.81^^88^889^41
 ;;^UTILITY(U,$J,358.3,17228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17228,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,17228,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,17228,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,17229,0)
 ;;=D86.82^^88^889^50
 ;;^UTILITY(U,$J,358.3,17229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17229,1,3,0)
 ;;=3^Sarcoidosis,Multiple Cranial Nerve Palsies
 ;;^UTILITY(U,$J,358.3,17229,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,17229,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,17230,0)
 ;;=D86.84^^88^889^44
 ;;^UTILITY(U,$J,358.3,17230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17230,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,17230,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,17230,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,17231,0)
 ;;=D86.85^^88^889^42
 ;;^UTILITY(U,$J,358.3,17231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17231,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,17231,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,17231,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,17232,0)
 ;;=D86.83^^88^889^40
 ;;^UTILITY(U,$J,358.3,17232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17232,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,17232,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,17232,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,17233,0)
 ;;=D84.1^^88^889^16
 ;;^UTILITY(U,$J,358.3,17233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17233,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,17233,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,17233,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,17234,0)
 ;;=D81.810^^88^889^5
 ;;^UTILITY(U,$J,358.3,17234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17234,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,17234,1,4,0)
 ;;=4^D81.810
